Loading…
Disclosed for 7 months, Jan 2014 to Jul 2014. This scheme is no longer reporting.
UTI - Contra Fund is an active equity fund in the Value / Contra category from UTI Mutual Fund. In July 2014 it disclosed 32 stocks worth ₹137 Cr, down ₹2.7 Cr from Jun 2014. Its largest positions were Reliance Industries Limited (6.6%), ICICI Bank Limited (6.4%), Infosys Limited (6.1%); the ten largest together made up 51.3% of the portfolio, and Banks was the biggest sector at 25.5% of its equity. Cash and debt stood at 3.5%. Compared with Jun 2014 the fund entered 0 new stocks and exited 1.
Top-10 weight is higher than 96% of peers
Holds more stocks than 7% of peers
Holds more cash than 41% of peers
Every line the fund disclosed, with the change against Jun 2014. Click a column to sort; click a company to see every fund that owns it.
None.
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Jun 2014, the weight rose most in Diversified FMCG (+1.1 pts) and Pharmaceuticals & Biotechnology (+0.6 pts), and fell most in Petroleum Products (−2.1 pts) and Construction (−0.7 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Jan 2014 | Apr 2014 | Jun 2014 | Jul 2014 |
|---|---|---|---|---|
| Banks | 19.8% | 25.8% | 26.2% | 25.5% |
| IT - Software | 15.2% | 11.2% | 10.2% | 10.7% |
| Diversified FMCG | 11.6% | 11.0% | 8.4% | 9.6% |
| Petroleum Products | 10.5% | 11.1% | 11.4% | 9.4% |
| Automobiles | 5.6% | 6.6% | 6.7% | 7.2% |
| Entertainment | 6.2% | 5.1% | 5.4% | 5.4% |
| Pharmaceuticals & Biotechnology | 5.3% | 4.6% | 3.9% | 4.5% |
| Construction | 3.3% | 4.1% | 4.9% | 4.2% |
| Diversified Metals | 3.0% | 2.8% | 3.9% | 4.0% |
| Ferrous Metals | 3.2% | 3.0% | 3.5% | 3.8% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| 1.9% |
| 1.9% |
| — |
| Jan 2014 | ₹117 Cr | 34 | 3.4% | 3.4% | — |